Johnson & Johnson reportedly has received initial takeover bids for its Ortho Clinical Diagnostics division from private equity groups including KKR, Bain Capital, BC Partners, Carlyle Group and Blackstone Group. Sources say the diagnostics business, which focuses on laboratory blood tests and blood screening tools, could pull in about $5 billion.
Private-equity firms make initial bids for J&J unit, sources say
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||